Key Points
- Director Yusheng Han bought 314,870 shares on March 31 at an average price of $17.36 (≈$5.47M), increasing his direct holdings to 17,672,676 shares—a 1.81% rise valued at roughly $306.8M.
- Burning Rock reported a quarterly loss of $0.21 per share with a negative net margin (−10.27%) and negative ROE (−9.98%); the stock has a market cap of about $174.3M and a 52‑week range of $2.18–$41.72.
- Analyst views are mixed but tilt negative—one upgrade to "Buy" was offset by a "Sell (D-)" reiteration and a MarketBeat consensus of "Sell"—while institutional ownership stands at about 30% with several funds recently adding or initiating positions.
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR - Get Free Report) Director Yusheng Han bought 314,870 shares of the firm's stock in a transaction that occurred on Tuesday, March 31st. The stock was purchased at an average cost of $17.36 per share, with a total value of $5,466,143.20. Following the completion of the transaction, the director directly owned 17,672,676 shares in the company, valued at $306,797,655.36. This represents a 1.81% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Burning Rock Biotech Stock Performance
BNR stock opened at $16.20 on Friday. The stock's 50 day simple moving average is $25.63 and its 200 day simple moving average is $19.39. The company has a market cap of $174.31 million, a P/E ratio of -20.51 and a beta of 1.59. Burning Rock Biotech Limited Sponsored ADR has a fifty-two week low of $2.18 and a fifty-two week high of $41.72.
Burning Rock Biotech (NASDAQ:BNR - Get Free Report) last announced its quarterly earnings data on Saturday, February 14th. The company reported ($0.21) EPS for the quarter. The firm had revenue of $18.05 million during the quarter. Burning Rock Biotech had a negative net margin of 10.27% and a negative return on equity of 9.98%.
Institutional Trading of Burning Rock Biotech
Institutional investors and hedge funds have recently modified their holdings of the stock. Crcm LP boosted its position in shares of Burning Rock Biotech by 121.8% during the fourth quarter. Crcm LP now owns 491,426 shares of the company's stock valued at $9,902,000 after buying an additional 269,851 shares during the last quarter. Prospera Financial Services Inc purchased a new stake in Burning Rock Biotech in the 3rd quarter valued at $214,000. Marshall Wace LLP purchased a new stake in Burning Rock Biotech in the 4th quarter valued at $220,000. Finally, China Universal Asset Management Co. Ltd. bought a new position in Burning Rock Biotech during the 3rd quarter valued at $26,000. 30.03% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have commented on BNR shares. Wall Street Zen upgraded shares of Burning Rock Biotech from a "hold" rating to a "buy" rating in a research note on Saturday, January 17th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Burning Rock Biotech in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Burning Rock Biotech presently has a consensus rating of "Sell".
Read Our Latest Report on BNR
Burning Rock Biotech Company Profile
(
Get Free Report)
Burning Rock Biotech (NASDAQ: BNR) is a precision oncology company specializing in the development and commercialization of next-generation sequencing (NGS)–based cancer diagnostics. The company's core business revolves around liquid biopsy tests, which analyze circulating tumor DNA (ctDNA) from blood samples to detect genetic mutations associated with various solid tumors. By enabling noninvasive profiling of tumor genomics, Burning Rock Biotech aims to guide personalized therapy decisions and monitor treatment response in cancer patients.
Founded in 2014 and headquartered in Guangzhou, China, Burning Rock Biotech launched its first clinical services in the mid-2010s and subsequently expanded its laboratory network across major Chinese cities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
